<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>3-Hydroxy-3-Methylglutaric Aciduria - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-name-link {
            color: inherit;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
        }

        .item-name-link:hover {
            text-decoration-thickness: 2px;
        }

        .missing-disease-name {
            color: #991b1b;
            border-bottom: 1px dotted #dc2626;
        }

        .curation-gap-badge {
            display: inline-flex;
            align-items: center;
            margin-left: 8px;
            padding: 2px 8px;
            border-radius: 999px;
            font-size: 0.72rem;
            font-weight: 700;
            letter-spacing: 0.01em;
            text-transform: uppercase;
            background: #fef2f2;
            border: 1px solid #fecaca;
            color: #b91c1c;
            vertical-align: middle;
        }

        .missing-ontology-link {
            color: #b91c1c !important;
            text-decoration: underline dotted;
            text-underline-offset: 2px;
        }

        .dismech-inline-link {
            margin-left: 6px;
            font-size: 0.78rem;
            font-weight: 600;
            color: #0369a1;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
            white-space: nowrap;
        }

        .dismech-inline-link:hover {
            text-decoration-thickness: 2px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>3-Hydroxy-3-Methylglutaric Aciduria</span>
        </nav>

        <header class="page-header">
            <h1>3-Hydroxy-3-Methylglutaric Aciduria</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Mendelian</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0009520" target="_blank">
                        MONDO:0009520
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Organic Acidemia</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Inborn Error of Metabolism</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                3-Hydroxy-3-methylglutaric aciduria (HMGCLD) is an autosomal recessive inborn error of metabolism caused by biallelic pathogenic variants in HMGCL, encoding mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase. This enzyme catalyzes the final step of both ketogenesis and leucine degradation, cleaving HMG-CoA to acetyl-CoA and acetoacetate. Deficiency results in failure to produce ketone bodies during catabolic stress and accumulation of leucine-derived toxic organic acids. Acute metabolic crises feature hypoketotic hypoglycemia, metabolic acidosis, and hyperammonemia, with neurological sequelae including seizures, developmental delay, and white matter abnormalities. More than 95% of reported patients experience at least one metabolic decompensation episode, with approximately 42% having neonatal onset. Mortality is reported at approximately 16%, while over 60% of survivors achieve normal development with appropriate management.

            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">14</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">HMGCL molecular function deficiency</div>
                
                <div class="item-desc">Biallelic pathogenic variants in HMGCL reduce mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase catalytic activity.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        hepatocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000182" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        HMGCL
                        
                    </span>
                    
                </div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        mitochondrion
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005739" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32059735" target="_blank">PMID:32059735</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is an autosomal recessive disorder of ketogenesis and leucine degradation due to mutations in HMGCL."</div>
                
                
                <div class="evidence-explanation">Supports HMGCL molecular deficiency as the initiating genetic and enzymatic defect.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Ketogenesis failure and energy crisis</div>
                
                <div class="item-desc">Loss of HMGCL-mediated HMG-CoA cleavage abolishes ketogenesis, depriving brain and heart of essential energy substrates during fasting and catabolic stress. This produces hypoketotic hypoglycemia and metabolic acidosis during acute crises.
</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        ketone body metabolic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0046950" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        fatty acid beta-oxidation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006635" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        liver
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002107" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32059735" target="_blank">PMID:32059735</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"More than 95% of patients presented with acute metabolic decompensation. Most patients manifested within the first year of life, 42.4% already neonatally."</div>
                
                
                <div class="evidence-explanation">Systematic review of 211 patients demonstrates near-universal acute metabolic crises from ketogenesis failure.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Leucine catabolic block and organic acid accumulation</div>
                
                <div class="item-desc">HMGCL is also required for leucine degradation. Blockade causes upstream accumulation of leucine-derived metabolites including 3-hydroxy-3-methylglutaric acid, 3-methylglutaconic acid, 3-methylglutaric acid, and 3-hydroxyisovaleric acid. Illness-driven leucine flux increases toxic metabolite excretion, implying leucine-derived toxicity is particularly prominent under inflammatory and catabolic stress.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        hepatocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000182" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        leucine catabolic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006552" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        branched-chain amino acid catabolic process
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0009083" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        mitochondrial matrix
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005759" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) deficiency can be a very severe disorder that typically presents with acute metabolic decompensation with features of hypoketotic hypoglycemia, hyperammonemia, and metabolic acidosis."</div>
                
                
                <div class="evidence-explanation">Confirms the clinical presentation from toxic metabolite accumulation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Acyl-CoA disequilibrium and secondary hyperammonemia</div>
                
                <div class="item-desc">Chronic HMGCL deficiency and acute crises each produce distinct abnormal hepatic acyl-CoA patterns. Leucine metabolite loading increases leucine-related acyl-CoAs while depleting acetyl-CoA. Acetyl-CoA depletion impairs N-acetylglutamate synthesis, which is required for urea cycle activation via carbamoyl phosphate synthetase 1, producing secondary hyperammonemia. This mechanism was confirmed by carglumate rescue of hyperammonemia in a liver-specific HMGCL knockout mouse model.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        hepatocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000182" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        urea cycle
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0000050" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        liver
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002107" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        mitochondrial matrix
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005759" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23861731" target="_blank">PMID:23861731</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chronic HL deficiency and acute crises each produced distinct abnormal liver acyl-CoA patterns, which would not be predictable from levels of urine organic acids and plasma acylcarnitines."</div>
                
                
                <div class="evidence-explanation">Demonstrates acyl-CoA disruption as a core pathological mechanism in liver-specific HMGCL KO mice.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23861731" target="_blank">PMID:23861731</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"KIC-induced hyperammonemia improved following administration of carglumate (N-carbamyl-L-glutamic acid), which substitutes for the product of an acetyl-CoA-dependent reaction essential for urea cycle function"</div>
                
                
                <div class="evidence-explanation">Confirms acetyl-CoA-linked mechanism for secondary hyperammonemia and carglumate responsiveness.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">HMG-mediated neurotoxicity via mitochondrial dysfunction</div>
                
                <div class="item-desc">The major accumulating metabolite 3-hydroxy-3-methylglutaric acid (HMG) directly disrupts brain mitochondrial function. In neonatal rat brain, HMG exposure reduces succinate dehydrogenase and respiratory chain complex II-III and IV activity in the cerebral cortex and striatum, impairs antioxidant defenses, and increases DRP1 levels indicating mitochondrial fission. These mechanisms connect metabolite accumulation to the neurological vulnerability observed early in life.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neuron
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000540" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        mitochondrial electron transport, NADH to ubiquinone
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006120" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        response to oxidative stress
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006979" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        mitochondrial fission
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0000266" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        cerebral cortex
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000956" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        striatum
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002435" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39062136" target="_blank">PMID:39062136</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"HMG decreased the activities of succinate dehydrogenase and respiratory chain complexes II-III and IV in the cortex. HMG also decreased the activities of citrate synthase and succinate dehydrogenase, as well as complex IV in the striatum."</div>
                
                
                <div class="evidence-explanation">Quantitative evidence of HMG-mediated bioenergetic disruption in brain regions.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39062136" target="_blank">PMID:39062136</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"HMG further increased DRP1 levels in the cortex, indicating mitochondrial fission."</div>
                
                
                <div class="evidence-explanation">Demonstrates HMG drives mitochondrial network fragmentation in brain tissue.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39062136" target="_blank">PMID:39062136</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"HMG-injected animals showed impaired performance in all sensorimotor tests examined."</div>
                
                
                <div class="evidence-explanation">Links HMG exposure directly to neurodevelopmental impairment in an animal model.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">⬡</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Leucine_catabolic_block_and_organic_acid_accumulation[&#34;Leucine catabolic block and organic acid accumulation&#34;]
    HMGCL_molecular_function_deficiency[&#34;HMGCL molecular function deficiency&#34;]
    HMG_mediated_neurotoxicity_via_mitochondrial_dysfunction[&#34;HMG-mediated neurotoxicity via mitochondrial dysfunction&#34;]
    Ketogenesis_failure_and_energy_crisis[&#34;Ketogenesis failure and energy crisis&#34;]
    Acyl_CoA_disequilibrium_and_secondary_hyperammonemia[&#34;Acyl-CoA disequilibrium and secondary hyperammonemia&#34;]

    HMGCL_molecular_function_deficiency --&gt; Ketogenesis_failure_and_energy_crisis
    HMGCL_molecular_function_deficiency --&gt; Leucine_catabolic_block_and_organic_acid_accumulation
    Leucine_catabolic_block_and_organic_acid_accumulation --&gt; Acyl_CoA_disequilibrium_and_secondary_hyperammonemia
    Leucine_catabolic_block_and_organic_acid_accumulation --&gt; HMG_mediated_neurotoxicity_via_mitochondrial_dysfunction

    style Leucine_catabolic_block_and_organic_acid_accumulation fill:#dbeafe
    style HMGCL_molecular_function_deficiency fill:#dbeafe
    style HMG_mediated_neurotoxicity_via_mitochondrial_dysfunction fill:#dbeafe
    style Ketogenesis_failure_and_energy_crisis fill:#dbeafe
    style Acyl_CoA_disequilibrium_and_secondary_hyperammonemia fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">14</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Digestive<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Metabolism<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Musculoskeletal<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Nervous System<span class="pill-count">(6)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Other<span class="pill-count">(2)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Cardiomyopathy
                        
                        <span class="phenotype-freq">VERY_RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001638" target="_blank">
                                Cardiomyopathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001638)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Cardiomyopathy is a rare but potentially fatal complication of HMGCLD, reported in systematic reviews and case series. Cardiac tissue dependence on ketone bodies during stress may explain vulnerability.</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Vomiting
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002013" target="_blank">
                                Vomiting
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002013)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Vomiting is commonly described during metabolic decompensation episodes in HMGCLD case series.</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hepatomegaly
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002240" target="_blank">
                                Hepatomegaly
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002240)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Hepatomegaly has been reported during acute metabolic crises in HMGCLD case reports.</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Metabolism
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Metabolic acidosis
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001942" target="_blank">
                                Metabolic acidosis
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001942)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"49 patients (79.03%) developed metabolic acidosis."</div>
                
                
                <div class="evidence-explanation">Quantifies metabolic acidosis frequency at 79% in a large molecularly confirmed cohort.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32059735" target="_blank">PMID:32059735</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"More than 95% of patients presented with acute metabolic decompensation."</div>
                
                
                <div class="evidence-explanation">Systematic review confirms near-universal metabolic decompensation with acidosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hypoglycemia
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001943" target="_blank">
                                Hypoglycemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001943)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"38 patients (61.29%) presented with hypoglycemia"</div>
                
                
                <div class="evidence-explanation">Quantifies hypoglycemia at diagnosis in 61% of a 62-patient cohort.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3099065" target="_blank">PMID:3099065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"In the first year of life infants with HMG-CoA-LD run a high risk of developing severe hypoglycaemia which can lead to death if prompt intervention does not occur."</div>
                
                
                <div class="evidence-explanation">Foundational review emphasizing life-threatening hypoglycemia in infancy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Musculoskeletal
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Muscular hypotonia
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001252" target="_blank">
                                Hypotonia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001252)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"hypotonic 3/62 (4.83%)"</div>
                
                
                <div class="evidence-explanation">Quantifies hypotonia in the 62-patient cohort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">6</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Seizures
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001250" target="_blank">
                                Seizure
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001250)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Common neurological findings include seizures 17/62 (27.41%)"</div>
                
                
                <div class="evidence-explanation">Quantifies seizure frequency at 27.4% in a 62-patient cohort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Lethargy
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001254" target="_blank">
                                Lethargy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001254)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Lethargy is a common feature during metabolic decompensation episodes in HMGCLD, progressing to encephalopathy or coma in severe crises.</div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Global developmental delay
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001263" target="_blank">
                                Global developmental delay
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001263)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32059735" target="_blank">PMID:32059735</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The neurologic long-term outcome was favorable with 62.6% of patients showing normal development."</div>
                
                
                <div class="evidence-explanation">Most patients develop normally, but a significant minority has long-term neurologic sequelae.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Leukoencephalopathy
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002352" target="_blank">
                                Leukoencephalopathy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002352)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"An MRI of the brain exhibited nonspecific periventricular and deep white matter hyperintense signal changes in 16 patients (25.80%)"</div>
                
                
                <div class="evidence-explanation">Quantifies white matter abnormality frequency at 25.8% in the cohort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Speech delay
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000750" target="_blank">
                                Delayed speech and language development
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000750)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"speech delay 7/62 (11.29%)"</div>
                
                
                <div class="evidence-explanation">Quantifies speech delay frequency in a molecularly confirmed cohort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Cerebral atrophy
                        
                        <span class="phenotype-freq">VERY_RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0002059" target="_blank">
                                Cerebral atrophy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0002059)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"cerebral atrophy was found in one (1/62; 1.612%) patient."</div>
                
                
                <div class="evidence-explanation">Quantifies cerebral atrophy as a rare but documented finding.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hyperammonemia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001987" target="_blank">
                                Hyperammonemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001987)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23861731" target="_blank">PMID:23861731</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hyperammonemia and hypoglycemia, cardinal features of many inborn errors of acyl-CoA metabolism, occurred spontaneously in some HLLKO mice and were inducible by administering KIC."</div>
                
                
                <div class="evidence-explanation">Hyperammonemia demonstrated mechanistically in the liver-specific HMGCL KO mouse model.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Acute liver failure
                        
                        <span class="phenotype-freq">VERY_RARE</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0006554" target="_blank">
                                Acute hepatic failure
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0006554)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"there were two patients that presented atypically-one with fulminant liver failure and the other with isolated developmental delay."</div>
                
                
                <div class="evidence-explanation">Documents fulminant liver failure as an atypical presentation of HMGCLD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    HMGCL pathogenic variants
                    
                </div>
                
                <div class="item-meta">
                    
                    <span class="tag" style="background: #bfdbfe; color: #1e40af;">Autosomal recessive</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32059735" target="_blank">PMID:32059735</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"This comprehensive data analysis provides a systematic overview on all published cases with HMGCLD including a list of all known HMGCL mutations."</div>
                
                
                <div class="evidence-explanation">Provides the most comprehensive catalog of HMGCL mutations and associated phenotypes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"This is the largest cohort of HMGCLD patients reported from Saudi Arabia, signifying this disorder as a likely life-threatening disease, with a high prevalence in the region."</div>
                
                
                <div class="evidence-explanation">Largest regional cohort demonstrating population-specific variant enrichment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">8</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Dietary protein and leucine restriction
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000088" target="_blank">
                            MAXO:0000088
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Restriction of leucine and total protein intake is the cornerstone of long-term management. All patients in contemporary cohorts receive protein-restricted diets, with some also receiving fat restriction. Dietary management is well tolerated and helps prevent metabolic crises.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"All patients have been on long-term protein restriction, and those diagnosed more recently have had additional fat restriction."</div>
                
                
                <div class="evidence-explanation">Confirms universal use of protein restriction in contemporary management.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Our findings suggest that diagnosis at an early stage with careful dietary management may avoid metabolic crises."</div>
                
                
                <div class="evidence-explanation">Large cohort supporting dietary management for crisis prevention.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Avoidance of fasting
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000088" target="_blank">
                            MAXO:0000088
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Prevention of prolonged fasting is critical because ketogenesis failure means the patient cannot generate alternative energy substrates during fasting. Emergency carbohydrate plans are used during illness.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3099065" target="_blank">PMID:3099065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"The metabolic crisis develops when the infant is first introduced to dietary protein soon after birth, or later, when a reduced intake of glucose, often during a viral infection, results in a drain on the infant&#39;s circulating glucose levels."</div>
                
                
                <div class="evidence-explanation">Identifies fasting and reduced glucose intake as key crisis triggers.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    L-carnitine supplementation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">L-carnitine is commonly prescribed in long-term management to support detoxification and excretion of accumulating organic acids as acylcarnitine conjugates. Used in most patients across contemporary cohorts.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Most patients take L-carnitine."</div>
                
                
                <div class="evidence-explanation">Confirms widespread use of carnitine supplementation in HMGCLD management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Exogenous ketone therapy (sodium D,L-3-hydroxybutyrate)
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Exogenous ketone supplementation (sodium D,L-3-hydroxybutyrate, up to 900 mg/kg/day) bypasses impaired endogenous ketogenesis to provide alternative energy substrates for brain and heart. Used in both acute management and chronic adjunct therapy. Reported as well tolerated and effective in clinical case series.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"five of nine patients have used 900 mg/kg/day of sodium D,L 3-hydroxybutyrate in combination with intravenous dextrose-containing fluids"</div>
                
                
                <div class="evidence-explanation">Documents high-dose exogenous ketone use in acute management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Acute decompensation management
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Emergency treatment includes rapid glucose provision (IV dextrose and/or frequent oral carbohydrate), cessation of protein intake, and correction of metabolic acidosis and hyperammonemia. Prompt intervention is essential to prevent death.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3099065" target="_blank">PMID:3099065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"In the first year of life infants with HMG-CoA-LD run a high risk of developing severe hypoglycaemia which can lead to death if prompt intervention does not occur."</div>
                
                
                <div class="evidence-explanation">Foundational evidence for the critical importance of prompt acute intervention.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Dietary management in patients with HMGCL deficiency is well tolerated, and rapid institution of acute supportive metabolic treatment is imperative to optimizing survival and improve outcomes in this disorder."</div>
                
                
                <div class="evidence-explanation">Contemporary confirmation that rapid supportive care is essential for survival.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Newborn screening
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000124" target="_blank">
                            MAXO:0000124
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Tandem mass spectrometry screening using elevated C5-OH (3-hydroxyisovalerylcarnitine) enables presymptomatic diagnosis. Confirmation follows with urine organic acid analysis and molecular testing of HMGCL. Early detection allows initiation of dietary management before metabolic decompensation.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35646072" target="_blank">PMID:35646072</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"Our findings suggest that diagnosis at an early stage with careful dietary management may avoid metabolic crises."</div>
                
                
                <div class="evidence-explanation">Supports early detection and treatment to prevent metabolic crises.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Genetic counseling
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000079" target="_blank">
                            MAXO:0000079
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Genetic counseling for affected families including discussion of autosomal recessive inheritance, 25% recurrence risk, and options for carrier testing, prenatal diagnosis, and preimplantation genetic testing.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32059735" target="_blank">PMID:32059735</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is an autosomal recessive disorder of ketogenesis and leucine degradation due to mutations in HMGCL."</div>
                
                
                <div class="evidence-explanation">Autosomal recessive etiology supports genetic counseling for affected families.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Carglumic acid for hyperammonemia
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Carglumic acid (N-carbamyl-L-glutamic acid) is a synthetic analog of N-acetylglutamate that can rescue hyperammonemia by activating carbamoyl phosphate synthetase 1 in the urea cycle, bypassing the acetyl-CoA-dependent NAG synthesis that is impaired in HMGCLD. Demonstrated effective in a mouse model of HMGCLD.
</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23861731" target="_blank">PMID:23861731</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"KIC-induced hyperammonemia improved following administration of carglumate (N-carbamyl-L-glutamic acid), which substitutes for the product of an acetyl-CoA-dependent reaction essential for urea cycle function"</div>
                
                
                <div class="evidence-explanation">Demonstrates carglumate efficacy for hyperammonemia in the HMGCL KO mouse model.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    3-Hydroxy-3-methylglutaric acid (HMG)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                <div class="item-desc">Context: Major accumulating urinary organic acid in HMGCLD. Also the primary metabolite tested for neurotoxicity, shown to disrupt brain mitochondrial function in neonatal rat models.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39062136" target="_blank">PMID:39062136</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"3-Hydroxy-3-methylglutaric acidemia (HMGA) is a neurometabolic inherited disorder characterized by the predominant accumulation of 3-hydroxy-3-methylglutaric acid (HMG) in the brain and biological fluids of patients."</div>
                
                
                <div class="evidence-explanation">Identifies HMG as the predominant accumulating metabolite.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    3-Methylglutaconic acid (3-MGC)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                <div class="item-desc">Context: Characteristic urinary organic acid elevated in HMGCLD. Its CoA ester (trans-3MGC-CoA) is implicated as a reactive metabolite capable of non-enzymatic protein acylation (3MGCylation) in the mitochondrial matrix.
</div>
                
                
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    3-Hydroxyisovalerylcarnitine (C5-OH)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                <div class="item-desc">Context: Elevated C5-OH acylcarnitine in plasma is the primary newborn screening marker for HMGCLD, detectable by tandem mass spectrometry.
</div>
                
                
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    3-Methylglutaric acid (3-MGL)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(INCREASED)</span>
                    
                </div>
                
                <div class="item-desc">Context: Urinary organic acid marker elevated in HMGCLD, part of the characteristic metabolite profile used for biochemical diagnosis.
</div>
                
                
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Ketone bodies
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(DECREASED)</span>
                    
                </div>
                
                <div class="item-desc">Context: Absent or inappropriately low ketones during fasting and illness is a hallmark biochemical finding. Non-ketotic or hypoketotic hypoglycemia distinguishes HMGCLD from other organic acidemias.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36771238" target="_blank">PMID:36771238</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-HUMAN_CLINICAL">Human Clinical</span>
                    
                </div>
                
                <div class="evidence-snippet">"3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) deficiency can be a very severe disorder that typically presents with acute metabolic decompensation with features of hypoketotic hypoglycemia"</div>
                
                
                <div class="evidence-explanation">Confirms hypoketotic hypoglycemia as a defining feature.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Acetyl-CoA
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(DECREASED)</span>
                    
                </div>
                
                <div class="item-desc">Context: Hepatic acetyl-CoA levels are reduced during leucine metabolite loading in HMGCL-deficient liver, contributing to impaired gluconeogenesis and urea cycle activation.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23861731" target="_blank">PMID:23861731</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                    <span class="evidence-source source-MODEL_ORGANISM">Model Organism</span>
                    
                </div>
                
                <div class="evidence-snippet">"KIC loading also increased levels of several leucine-related acyl-CoAs and reduced acetyl-CoA levels."</div>
                
                
                <div class="evidence-explanation">Direct demonstration of acetyl-CoA depletion in HMGCL-deficient hepatocytes under leucine stress.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: 3-Hydroxy-3-Methylglutaric Aciduria
category: Mendelian
creation_date: &#39;2026-02-23T00:00:00Z&#39;
updated_date: &#39;2026-02-28T02:53:27Z&#39;
synonyms:
- HMG-CoA lyase deficiency
- HMGCLD
- 3-Hydroxy-3-methylglutaric acidemia
- Hydroxymethylglutaric aciduria
description: &#39;3-Hydroxy-3-methylglutaric aciduria (HMGCLD) is an autosomal recessive inborn error of metabolism caused by
  biallelic pathogenic variants in HMGCL, encoding mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase. This enzyme catalyzes
  the final step of both ketogenesis and leucine degradation, cleaving HMG-CoA to acetyl-CoA and acetoacetate. Deficiency
  results in failure to produce ketone bodies during catabolic stress and accumulation of leucine-derived toxic organic acids.
  Acute metabolic crises feature hypoketotic hypoglycemia, metabolic acidosis, and hyperammonemia, with neurological sequelae
  including seizures, developmental delay, and white matter abnormalities. More than 95% of reported patients experience at
  least one metabolic decompensation episode, with approximately 42% having neonatal onset. Mortality is reported at approximately
  16%, while over 60% of survivors achieve normal development with appropriate management.

  &#39;
disease_term:
  preferred_term: 3-hydroxy-3-methylglutaric aciduria
  term:
    id: MONDO:0009520
    label: 3-hydroxy-3-methylglutaric aciduria
parents:
- Organic Acidemia
- Inborn Error of Metabolism
prevalence:
- population: Global
  percentage: Rare
  notes: &#39;Approximately 211 cases compiled in a 2020 systematic literature review. Higher prevalence in regions with high
    consanguinity such as Saudi Arabia, where a founder HMGCL variant c.122G&gt;A (p.Arg41Gln) is present.

    &#39;
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Two hundred eleven patients of whom relevant clinical data were available were included in this analysis.
    explanation: Systematic review compiling 211 published cases worldwide.
progression:
- phase: Neonatal onset
  age_range: 0-28 days
  notes: &#39;42.4% of patients present neonatally. Crises triggered by protein introduction or catabolic stress in the first
    days of life.

    &#39;
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Most patients manifested within the first year of life, 42.4% already neonatally.
    explanation: Quantifies neonatal onset frequency.
- phase: Acute metabolic decompensation
  notes: &#39;More than 95% of patients experience at least one metabolic crisis. Crises feature hypoketotic hypoglycemia, metabolic
    acidosis, and hyperammonemia. With age and dietary management, hypoglycemic attacks diminish.

    &#39;
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: More than 95% of patients presented with acute metabolic decompensation.
    explanation: Near-universal occurrence of metabolic crises in HMGCLD.
  - reference: PMID:3099065
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: As children with HMG-CoA-LD grow older the incidence of hypoglycaemic attacks diminishes and they usually develop
      normally.
    explanation: Improvement with age supports staged progression.
pathophysiology:
- name: HMGCL molecular function deficiency
  description: &#39;Biallelic pathogenic variants in HMGCL reduce mitochondrial
    3-hydroxy-3-methylglutaryl-CoA lyase catalytic activity.

    &#39;
  genes:
  - preferred_term: HMGCL
  cell_types:
  - preferred_term: hepatocyte
    term:
      id: CL:0000182
      label: hepatocyte
  locations:
  - preferred_term: mitochondrion
    term:
      id: GO:0005739
      label: mitochondrion
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is an autosomal recessive disorder of ketogenesis and leucine degradation due to mutations in HMGCL.
    explanation: Supports HMGCL molecular deficiency as the initiating genetic and enzymatic defect.
  downstream:
  - target: Ketogenesis failure and energy crisis
    description: Loss of HMGCL function blocks hepatic ketone body generation during catabolic states.
  - target: Leucine catabolic block and organic acid accumulation
    description: Loss of HMGCL function also blocks leucine degradation, causing upstream toxic organic acid accumulation.
- name: Ketogenesis failure and energy crisis
  description: &#39;Loss of HMGCL-mediated HMG-CoA cleavage abolishes ketogenesis,
    depriving brain and heart of essential energy substrates during fasting and
    catabolic stress. This produces hypoketotic hypoglycemia and metabolic
    acidosis during acute crises.

    &#39;
  biological_processes:
  - preferred_term: ketone body metabolic process
    term:
      id: GO:0046950
      label: ketone body metabolic process
  - preferred_term: fatty acid beta-oxidation
    term:
      id: GO:0006635
      label: fatty acid beta-oxidation
  locations:
  - preferred_term: liver
    term:
      id: UBERON:0002107
      label: liver
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: More than 95% of patients presented with acute metabolic decompensation. Most patients manifested within the
      first year of life, 42.4% already neonatally.
    explanation: Systematic review of 211 patients demonstrates near-universal acute metabolic crises from ketogenesis failure.
- name: Leucine catabolic block and organic acid accumulation
  description: &#39;HMGCL is also required for leucine degradation. Blockade causes upstream accumulation of leucine-derived metabolites
    including 3-hydroxy-3-methylglutaric acid, 3-methylglutaconic acid, 3-methylglutaric acid, and 3-hydroxyisovaleric acid.
    Illness-driven leucine flux increases toxic metabolite excretion, implying leucine-derived toxicity is particularly prominent
    under inflammatory and catabolic stress.

    &#39;
  biological_processes:
  - preferred_term: leucine catabolic process
    term:
      id: GO:0006552
      label: leucine catabolic process
  - preferred_term: branched-chain amino acid catabolic process
    term:
      id: GO:0009083
      label: branched-chain amino acid catabolic process
  cell_types:
  - preferred_term: hepatocyte
    term:
      id: CL:0000182
      label: hepatocyte
  locations:
  - preferred_term: mitochondrial matrix
    term:
      id: GO:0005759
      label: mitochondrial matrix
  evidence:
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) deficiency can be a very severe disorder that typically presents
      with acute metabolic decompensation with features of hypoketotic hypoglycemia, hyperammonemia, and metabolic acidosis.
    explanation: Confirms the clinical presentation from toxic metabolite accumulation.
  downstream:
  - target: Acyl-CoA disequilibrium and secondary hyperammonemia
  - target: HMG-mediated neurotoxicity via mitochondrial dysfunction
- name: Acyl-CoA disequilibrium and secondary hyperammonemia
  description: &#39;Chronic HMGCL deficiency and acute crises each produce distinct abnormal hepatic acyl-CoA patterns. Leucine
    metabolite loading increases leucine-related acyl-CoAs while depleting acetyl-CoA. Acetyl-CoA depletion impairs N-acetylglutamate
    synthesis, which is required for urea cycle activation via carbamoyl phosphate synthetase 1, producing secondary hyperammonemia.
    This mechanism was confirmed by carglumate rescue of hyperammonemia in a liver-specific HMGCL knockout mouse model.

    &#39;
  biological_processes:
  - preferred_term: urea cycle
    term:
      id: GO:0000050
      label: urea cycle
  cell_types:
  - preferred_term: hepatocyte
    term:
      id: CL:0000182
      label: hepatocyte
  locations:
  - preferred_term: liver
    term:
      id: UBERON:0002107
      label: liver
  - preferred_term: mitochondrial matrix
    term:
      id: GO:0005759
      label: mitochondrial matrix
  evidence:
  - reference: PMID:23861731
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Chronic HL deficiency and acute crises each produced distinct abnormal liver acyl-CoA patterns, which would not
      be predictable from levels of urine organic acids and plasma acylcarnitines.
    explanation: Demonstrates acyl-CoA disruption as a core pathological mechanism in liver-specific HMGCL KO mice.
  - reference: PMID:23861731
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: KIC-induced hyperammonemia improved following administration of carglumate (N-carbamyl-L-glutamic acid), which
      substitutes for the product of an acetyl-CoA-dependent reaction essential for urea cycle function
    explanation: Confirms acetyl-CoA-linked mechanism for secondary hyperammonemia and carglumate responsiveness.
- name: HMG-mediated neurotoxicity via mitochondrial dysfunction
  description: &#39;The major accumulating metabolite 3-hydroxy-3-methylglutaric acid (HMG) directly disrupts brain mitochondrial
    function. In neonatal rat brain, HMG exposure reduces succinate dehydrogenase and respiratory chain complex II-III and
    IV activity in the cerebral cortex and striatum, impairs antioxidant defenses, and increases DRP1 levels indicating mitochondrial
    fission. These mechanisms connect metabolite accumulation to the neurological vulnerability observed early in life.

    &#39;
  biological_processes:
  - preferred_term: mitochondrial electron transport, NADH to ubiquinone
    term:
      id: GO:0006120
      label: mitochondrial electron transport, NADH to ubiquinone
  - preferred_term: response to oxidative stress
    term:
      id: GO:0006979
      label: response to oxidative stress
  - preferred_term: mitochondrial fission
    term:
      id: GO:0000266
      label: mitochondrial fission
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  - preferred_term: striatum
    term:
      id: UBERON:0002435
      label: striatum
  evidence:
  - reference: PMID:39062136
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: HMG decreased the activities of succinate dehydrogenase and respiratory chain complexes II-III and IV in the
      cortex. HMG also decreased the activities of citrate synthase and succinate dehydrogenase, as well as complex IV in
      the striatum.
    explanation: Quantitative evidence of HMG-mediated bioenergetic disruption in brain regions.
  - reference: PMID:39062136
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: HMG further increased DRP1 levels in the cortex, indicating mitochondrial fission.
    explanation: Demonstrates HMG drives mitochondrial network fragmentation in brain tissue.
  - reference: PMID:39062136
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: HMG-injected animals showed impaired performance in all sensorimotor tests examined.
    explanation: Links HMG exposure directly to neurodevelopmental impairment in an animal model.
phenotypes:
- name: Metabolic acidosis
  frequency: VERY_FREQUENT
  description: &#39;High-anion-gap metabolic acidosis during metabolic decompensation, reported in 79% of patients in a 62-patient
    Saudi cohort.

    &#39;
  phenotype_term:
    preferred_term: Metabolic acidosis
    term:
      id: HP:0001942
      label: Metabolic acidosis
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 49 patients (79.03%) developed metabolic acidosis.
    explanation: Quantifies metabolic acidosis frequency at 79% in a large molecularly confirmed cohort.
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: More than 95% of patients presented with acute metabolic decompensation.
    explanation: Systematic review confirms near-universal metabolic decompensation with acidosis.
- name: Hypoglycemia
  frequency: VERY_FREQUENT
  description: &#39;Hypoketotic or non-ketotic hypoglycemia is a cardinal feature, resulting from failure of ketogenesis during
    fasting. Reported in 61% of patients at initial diagnosis in a large cohort.

    &#39;
  phenotype_term:
    preferred_term: Hypoglycemia
    term:
      id: HP:0001943
      label: Hypoglycemia
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 38 patients (61.29%) presented with hypoglycemia
    explanation: Quantifies hypoglycemia at diagnosis in 61% of a 62-patient cohort.
  - reference: PMID:3099065
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: In the first year of life infants with HMG-CoA-LD run a high risk of developing severe hypoglycaemia which can
      lead to death if prompt intervention does not occur.
    explanation: Foundational review emphasizing life-threatening hypoglycemia in infancy.
- name: Hyperammonemia
  frequency: FREQUENT
  description: &#39;Secondary hyperammonemia occurs during metabolic crises, sometimes exceeding 1000 umol/L. Mechanism involves
    acetyl-CoA depletion impairing N-acetylglutamate-dependent urea cycle activation.

    &#39;
  phenotype_term:
    preferred_term: Hyperammonemia
    term:
      id: HP:0001987
      label: Hyperammonemia
  evidence:
  - reference: PMID:23861731
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: Hyperammonemia and hypoglycemia, cardinal features of many inborn errors of acyl-CoA metabolism, occurred spontaneously
      in some HLLKO mice and were inducible by administering KIC.
    explanation: Hyperammonemia demonstrated mechanistically in the liver-specific HMGCL KO mouse model.
- name: Seizures
  frequency: FREQUENT
  description: &#39;Seizures occur in approximately 27% of patients, typically during metabolic decompensation or as a result
    of neurological injury.

    &#39;
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Common neurological findings include seizures 17/62 (27.41%)
    explanation: Quantifies seizure frequency at 27.4% in a 62-patient cohort.
- name: Lethargy
  frequency: FREQUENT
  description: &#39;Reduced arousal and lethargy during decompensation events, often progressing to encephalopathy or coma in
    severe crises.

    &#39;
  phenotype_term:
    preferred_term: Lethargy
    term:
      id: HP:0001254
      label: Lethargy
  notes: Lethargy is a common feature during metabolic decompensation episodes in HMGCLD, progressing to encephalopathy or coma in severe crises.
- name: Global developmental delay
  frequency: OCCASIONAL
  description: &#39;Developmental delay occurs in a subset of patients, with 62.6% achieving normal development in a systematic
    review. Learning disability was reported in 24% and developmental delay in 9.7% of a Saudi cohort.

    &#39;
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The neurologic long-term outcome was favorable with 62.6% of patients showing normal development.
    explanation: Most patients develop normally, but a significant minority has long-term neurologic sequelae.
- name: Vomiting
  frequency: FREQUENT
  description: &#39;Recurrent vomiting during metabolic crises, often the presenting symptom triggering evaluation and emergency
    management.

    &#39;
  phenotype_term:
    preferred_term: Vomiting
    term:
      id: HP:0002013
      label: Vomiting
  notes: Vomiting is commonly described during metabolic decompensation episodes in HMGCLD case series.
- name: Leukoencephalopathy
  frequency: OCCASIONAL
  description: &#39;MRI white matter hyperintensities were observed in 25.8% of patients in a Saudi cohort, reflecting periventricular
    and deep white matter injury from metabolic crises.

    &#39;
  phenotype_term:
    preferred_term: Leukoencephalopathy
    term:
      id: HP:0002352
      label: Leukoencephalopathy
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: An MRI of the brain exhibited nonspecific periventricular and deep white matter hyperintense signal changes in
      16 patients (25.80%)
    explanation: Quantifies white matter abnormality frequency at 25.8% in the cohort.
- name: Hepatomegaly
  frequency: OCCASIONAL
  description: &#39;Hepatomegaly has been reported during acute metabolic crises, reflecting hepatic injury and metabolic stress.

    &#39;
  phenotype_term:
    preferred_term: Hepatomegaly
    term:
      id: HP:0002240
      label: Hepatomegaly
  notes: Hepatomegaly has been reported during acute metabolic crises in HMGCLD case reports.
- name: Muscular hypotonia
  frequency: OCCASIONAL
  description: &#39;Hypotonia was reported in approximately 5% of a Saudi cohort as a neurological finding.

    &#39;
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: hypotonic 3/62 (4.83%)
    explanation: Quantifies hypotonia in the 62-patient cohort.
- name: Speech delay
  frequency: OCCASIONAL
  description: &#39;Speech delay was present in 11.3% of patients in a Saudi cohort, reflecting neurodevelopmental vulnerability.

    &#39;
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: speech delay 7/62 (11.29%)
    explanation: Quantifies speech delay frequency in a molecularly confirmed cohort.
- name: Cerebral atrophy
  frequency: VERY_RARE
  description: &#39;Cerebral atrophy was found in 1/62 (1.6%) in a Saudi cohort, representing severe neurological sequelae.

    &#39;
  phenotype_term:
    preferred_term: Cerebral atrophy
    term:
      id: HP:0002059
      label: Cerebral atrophy
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: cerebral atrophy was found in one (1/62; 1.612%) patient.
    explanation: Quantifies cerebral atrophy as a rare but documented finding.
- name: Cardiomyopathy
  frequency: VERY_RARE
  description: &#39;Cardiomyopathy is a rare but potentially fatal complication of HMGCLD, mechanistically related to the dependence
    of cardiac tissue on ketone bodies as an energy source during stress.

    &#39;
  phenotype_term:
    preferred_term: Cardiomyopathy
    term:
      id: HP:0001638
      label: Cardiomyopathy
  notes: Cardiomyopathy is a rare but potentially fatal complication of HMGCLD, reported in systematic reviews and case series. Cardiac tissue dependence on ketone bodies during stress may explain vulnerability.
- name: Acute liver failure
  frequency: VERY_RARE
  description: &#39;Fulminant liver failure is an atypical but documented presentation of HMGCLD. One patient in an Australian
    cohort presented with isolated liver failure.

    &#39;
  phenotype_term:
    preferred_term: Acute hepatic failure
    term:
      id: HP:0006554
      label: Acute hepatic failure
  evidence:
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: there were two patients that presented atypically-one with fulminant liver failure and the other with isolated
      developmental delay.
    explanation: Documents fulminant liver failure as an atypical presentation of HMGCLD.
biochemical:
- name: 3-Hydroxy-3-methylglutaric acid (HMG)
  presence: INCREASED
  context: &#39;Major accumulating urinary organic acid in HMGCLD. Also the primary metabolite tested for neurotoxicity, shown
    to disrupt brain mitochondrial function in neonatal rat models.

    &#39;
  evidence:
  - reference: PMID:39062136
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: 3-Hydroxy-3-methylglutaric acidemia (HMGA) is a neurometabolic inherited disorder characterized by the predominant
      accumulation of 3-hydroxy-3-methylglutaric acid (HMG) in the brain and biological fluids of patients.
    explanation: Identifies HMG as the predominant accumulating metabolite.
- name: 3-Methylglutaconic acid (3-MGC)
  presence: INCREASED
  context: &#39;Characteristic urinary organic acid elevated in HMGCLD. Its CoA ester (trans-3MGC-CoA) is implicated as a reactive
    metabolite capable of non-enzymatic protein acylation (3MGCylation) in the mitochondrial matrix.

    &#39;
- name: 3-Hydroxyisovalerylcarnitine (C5-OH)
  presence: INCREASED
  context: &#39;Elevated C5-OH acylcarnitine in plasma is the primary newborn screening marker for HMGCLD, detectable by tandem
    mass spectrometry.

    &#39;
  notes: C5-OH acylcarnitine is the primary newborn screening marker for HMGCLD, used in tandem mass spectrometry-based screening panels.
- name: 3-Methylglutaric acid (3-MGL)
  presence: INCREASED
  context: &#39;Urinary organic acid marker elevated in HMGCLD, part of the characteristic metabolite profile used for biochemical
    diagnosis.

    &#39;
  notes: 3-Methylglutaric acid is part of the characteristic urinary organic acid profile used for biochemical diagnosis of HMGCLD.
- name: Ketone bodies
  presence: DECREASED
  context: &#39;Absent or inappropriately low ketones during fasting and illness is a hallmark biochemical finding. Non-ketotic
    or hypoketotic hypoglycemia distinguishes HMGCLD from other organic acidemias.

    &#39;
  evidence:
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) deficiency can be a very severe disorder that typically presents
      with acute metabolic decompensation with features of hypoketotic hypoglycemia
    explanation: Confirms hypoketotic hypoglycemia as a defining feature.
- name: Acetyl-CoA
  presence: DECREASED
  context: &#39;Hepatic acetyl-CoA levels are reduced during leucine metabolite loading in HMGCL-deficient liver, contributing
    to impaired gluconeogenesis and urea cycle activation.

    &#39;
  evidence:
  - reference: PMID:23861731
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: KIC loading also increased levels of several leucine-related acyl-CoAs and reduced acetyl-CoA levels.
    explanation: Direct demonstration of acetyl-CoA depletion in HMGCL-deficient hepatocytes under leucine stress.
genetic:
- name: HMGCL pathogenic variants
  inheritance:
  - name: Autosomal recessive
    evidence:
    - reference: PMID:32059735
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is an autosomal recessive disorder of ketogenesis
        and leucine degradation due to mutations in HMGCL.
      explanation: Directly states autosomal recessive inheritance.
  variants:
  - name: c.122G&gt;A (p.Arg41Gln) founder variant
    description: &#39;A Saudi Arabian founder variant accounting for 77.4% of affected individuals in a 62-patient cohort. This
      illustrates strong population structure and genotype clustering.

      &#39;
  features: &#39;Biallelic pathogenic variants in HMGCL cause deficiency of mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase
    (EC 4.1.3.4), which catalyzes cleavage of HMG-CoA to acetyl-CoA and acetoacetate. This is the final step of both ketogenesis
    and leucine degradation. Over 211 patients have been reported worldwide with various HMGCL mutations, with genotype-phenotype
    correlations influenced by residual enzyme activity and population-specific founder effects.

    &#39;
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: This comprehensive data analysis provides a systematic overview on all published cases with HMGCLD including
      a list of all known HMGCL mutations.
    explanation: Provides the most comprehensive catalog of HMGCL mutations and associated phenotypes.
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: This is the largest cohort of HMGCLD patients reported from Saudi Arabia, signifying this disorder as a likely
      life-threatening disease, with a high prevalence in the region.
    explanation: Largest regional cohort demonstrating population-specific variant enrichment.
treatments:
- name: Dietary protein and leucine restriction
  description: &#39;Restriction of leucine and total protein intake is the cornerstone of long-term management. All patients in
    contemporary cohorts receive protein-restricted diets, with some also receiving fat restriction. Dietary management is
    well tolerated and helps prevent metabolic crises.

    &#39;
  treatment_term:
    preferred_term: dietary intervention
    term:
      id: MAXO:0000088
      label: dietary intervention
  evidence:
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: All patients have been on long-term protein restriction, and those diagnosed more recently have had additional
      fat restriction.
    explanation: Confirms universal use of protein restriction in contemporary management.
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Our findings suggest that diagnosis at an early stage with careful dietary management may avoid metabolic crises.
    explanation: Large cohort supporting dietary management for crisis prevention.
- name: Avoidance of fasting
  description: &#39;Prevention of prolonged fasting is critical because ketogenesis failure means the patient cannot generate
    alternative energy substrates during fasting. Emergency carbohydrate plans are used during illness.

    &#39;
  treatment_term:
    preferred_term: dietary intervention
    term:
      id: MAXO:0000088
      label: dietary intervention
  evidence:
  - reference: PMID:3099065
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The metabolic crisis develops when the infant is first introduced to dietary protein soon after birth, or later,
      when a reduced intake of glucose, often during a viral infection, results in a drain on the infant&#39;s circulating glucose
      levels.
    explanation: Identifies fasting and reduced glucose intake as key crisis triggers.
- name: L-carnitine supplementation
  description: &#39;L-carnitine is commonly prescribed in long-term management to support detoxification and excretion of accumulating
    organic acids as acylcarnitine conjugates. Used in most patients across contemporary cohorts.

    &#39;
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Most patients take L-carnitine.
    explanation: Confirms widespread use of carnitine supplementation in HMGCLD management.
- name: Exogenous ketone therapy (sodium D,L-3-hydroxybutyrate)
  description: &#39;Exogenous ketone supplementation (sodium D,L-3-hydroxybutyrate, up to 900 mg/kg/day) bypasses impaired endogenous
    ketogenesis to provide alternative energy substrates for brain and heart. Used in both acute management and chronic adjunct
    therapy. Reported as well tolerated and effective in clinical case series.

    &#39;
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: five of nine patients have used 900 mg/kg/day of sodium D,L 3-hydroxybutyrate in combination with intravenous
      dextrose-containing fluids
    explanation: Documents high-dose exogenous ketone use in acute management.
- name: Acute decompensation management
  description: &#39;Emergency treatment includes rapid glucose provision (IV dextrose and/or frequent oral carbohydrate), cessation
    of protein intake, and correction of metabolic acidosis and hyperammonemia. Prompt intervention is essential to prevent
    death.

    &#39;
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:3099065
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: In the first year of life infants with HMG-CoA-LD run a high risk of developing severe hypoglycaemia which can
      lead to death if prompt intervention does not occur.
    explanation: Foundational evidence for the critical importance of prompt acute intervention.
  - reference: PMID:36771238
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Dietary management in patients with HMGCL deficiency is well tolerated, and rapid institution of acute supportive
      metabolic treatment is imperative to optimizing survival and improve outcomes in this disorder.
    explanation: Contemporary confirmation that rapid supportive care is essential for survival.
- name: Newborn screening
  description: &#39;Tandem mass spectrometry screening using elevated C5-OH (3-hydroxyisovalerylcarnitine) enables presymptomatic
    diagnosis. Confirmation follows with urine organic acid analysis and molecular testing of HMGCL. Early detection allows
    initiation of dietary management before metabolic decompensation.

    &#39;
  treatment_term:
    preferred_term: disease screening
    term:
      id: MAXO:0000124
      label: disease screening
  evidence:
  - reference: PMID:35646072
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Our findings suggest that diagnosis at an early stage with careful dietary management may avoid metabolic crises.
    explanation: Supports early detection and treatment to prevent metabolic crises.
- name: Genetic counseling
  description: &#39;Genetic counseling for affected families including discussion of autosomal recessive inheritance, 25% recurrence
    risk, and options for carrier testing, prenatal diagnosis, and preimplantation genetic testing.

    &#39;
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: MAXO:0000079
      label: genetic counseling
  evidence:
  - reference: PMID:32059735
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (HMGCLD) is an autosomal recessive disorder of ketogenesis
      and leucine degradation due to mutations in HMGCL.
    explanation: Autosomal recessive etiology supports genetic counseling for affected families.
- name: Carglumic acid for hyperammonemia
  description: &#39;Carglumic acid (N-carbamyl-L-glutamic acid) is a synthetic analog of N-acetylglutamate that can rescue hyperammonemia
    by activating carbamoyl phosphate synthetase 1 in the urea cycle, bypassing the acetyl-CoA-dependent NAG synthesis that
    is impaired in HMGCLD. Demonstrated effective in a mouse model of HMGCLD.

    &#39;
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
  evidence:
  - reference: PMID:23861731
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: KIC-induced hyperammonemia improved following administration of carglumate (N-carbamyl-L-glutamic acid), which
      substitutes for the product of an acetyl-CoA-dependent reaction essential for urea cycle function
    explanation: Demonstrates carglumate efficacy for hyperammonemia in the HMGCL KO mouse model.
notes: &#39;The 2024 discovery of non-enzymatic mitochondrial protein acylation (3MGCylation) by reactive trans-3-methylglutaconyl-CoA
  intermediates (PMID:39195517) represents an active research frontier that may help explain tissue-specific injury patterns.
  If validated in human tissues, this mechanism could open new therapeutic directions targeting reactive metabolite chemistry.
  The Devanapalli et al. 2023 case report on sodium D,L-3-hydroxybutyrate therapy (doi:10.20517/jtgg.2023.12) provides additional
  clinical detail on exogenous ketone use but lacks a PubMed-indexed PMID.

  &#39;
references: []
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/3-Hydroxy-3-Methylglutaric_Aciduria.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>